Effect of enalapril on the progression of chronic renal failure a randomized controlled trial

American Journal of Hypertension

Volumn 5, Issue 7, 1992, Pages 423-430

  Kamper, Anne Lise ^a   Strandgaard, Svend ^a   Leyssac, Paul P ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angiotensin converting enzyme inhibition; Chronic renal failure; Enalapril; Glomerular filtration rate; Progression of uremia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BICARBONATES; BLOOD PRESSURE; BODY WEIGHT; ENALAPRIL; HEMOGLOBINS; HUMAN; KIDNEY FAILURE, CHRONIC; MIDDLE AGE; POTASSIUM; SUPPORT, NON-U.S. GOV'T; UREA;

EID: 0026623273     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/5.7.423     Document Type: Article

References (35)

1. Mitch WE, Walser M, Buffington CA, Lemann J: A simple method for estimating progression of chronic renal failure. Lancet 1976;2:1326-1328.
2. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
3. Hostetter TH, Olson JL, Rennke HG, et al: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.
4. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982;307:652-660.
5. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-380.
6. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
7. Meyer TW, Anderson S, Rennke HG, Brenner BM: Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Am J Med 1985;79(3C):31-36.
8. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
9. Zatz R, Dunn R, Meyer TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77:1925-1930.
10. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987;31:752-759.
11. Jackson B, Johnston CI: The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 1988;6:495-501.
12. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989;36:526-536.
13. Reams GP, Bauer JH: Effects of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. Arch Intern Med 1986;146:2145-2148.
14. Bjdrck S, Nyberg G, Mulec H, et al: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986;293:471-474.
15. Parving H-H, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 1988;297:1086-1091.
16. Mathiesen E, Hommel E, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81-87.
17. Bjorck S, Mulec H, Johnsen S, et al: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 1990;300:904-907.
18. Kamper A-L, Thomsen HS, Nielsen SL, Strandgaard S: Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy. Scand J Urol Nephrol 1990;24:69-73.
19. Kelly JG, Doyle G, Donohue J, et al: Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol 1986;21:63-69.
20. Kampmann J, Siersbaek-Nielsen K, Kristensen M, Mol- holm-Hansen J: Rapid evaluation of creatinine clearance. Acta Med Scand 1974;196:517-520.
21. Brochner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271-274.
22. Brochner-Mortensen J: Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency. Scand J Clin Lab Invest 1981;41:91-97.
23. Fogo A, Yoshida Y, Glick AD, et al: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 1988;82:322-330.
24. Yoshida Y, Kawamura T, Ikoma M, et al: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989;36:626-635.
25. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982;285:685-688.
26. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;1:1175-1179.
27. Alvestrand A, Gutierrez A, Bucht H, Bergstrom J: Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 1988;3:624-631.
28. Maschio G, Oldrizzi L, Tessitore N, et al: Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 1982;22:371-376.
29. Rosman JB, Langer K, Brandi M, et al: Protein-restricted diet in chronic renal failure: a four year follow-up shows limited indications. Kidney Int 1989;36:S96-S102.
30. Keane WF, Kasiske BL, O'Donnell MP: Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 1988;47:157-160.
31. Eliahou HE, Cohen D, Hellberg B, et al: Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man. Am J Nephrol 1988;8:285-290.
32. Demarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes melli-tus. Ann Intern Med 1990;113:987-988.
33. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987;32:78-83.
34. Kamper A-L, Nielsen OJ: Effect of enalapril on hemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990;50:611-618.
35. Garcia DL, Anderson S, Rennke HG, Brenner BM: Anemia and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988;85:6142-6146.